258 related articles for article (PubMed ID: 28336205)
1. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of Andersen-Tawil Syndrome with Polymorphisms in hERG1 Gene (K897T) and SCN5A Gene (H558R) in One Family.
Jagodzińska M; Szperl M; Ponińska J; Kosiec A; Gajda R; Kukla P; Biernacka EK
Ann Noninvasive Electrocardiol; 2016 Mar; 21(2):189-95. PubMed ID: 26109178
[TBL] [Abstract][Full Text] [Related]
3. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
4. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
[TBL] [Abstract][Full Text] [Related]
7. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
[TBL] [Abstract][Full Text] [Related]
8. Phenotype variability in patients carrying KCNJ2 mutations.
Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygous mutations in
Polyak ME; Shestak A; Podolyak D; Zaklyazminskaya E
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843460
[TBL] [Abstract][Full Text] [Related]
10. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
11. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variants on SCN5A, KCNQ1, and KCNH2 in Patients with Ventricular Arrhythmias during Acute Myocardial Infarction in a Chinese Population.
Wang F; Liu Y; Liao H; Xue Y; Zhan X; Fang X; Liang Y; Wei W; Rao F; Zhang Q; Deng H; Lin Y; Liu F; Lin W; Zhang B; Wu S
Cardiology; 2020; 145(1):38-45. PubMed ID: 31751991
[TBL] [Abstract][Full Text] [Related]
13. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
[TBL] [Abstract][Full Text] [Related]
16. Results of genetic testing in 855 consecutive unrelated patients referred for long QT syndrome in a clinical laboratory.
Lieve KV; Williams L; Daly A; Richard G; Bale S; Macaya D; Chung WK
Genet Test Mol Biomarkers; 2013 Jul; 17(7):553-61. PubMed ID: 23631430
[TBL] [Abstract][Full Text] [Related]
17. Application of Multigene Panel Sequencing in Patients with Prolonged Rate-corrected QT Interval and No Pathogenic Variants Detected in KCNQ1, KCNH2, and SCN5A.
Seo SH; Kim SY; Cho SI; Park H; Lee S; Choi JM; Kim MJ; Lee JS; Ahn KJ; Song MK; Bae EJ; Park SS; Seong MW
Ann Lab Med; 2018 Jan; 38(1):54-58. PubMed ID: 29071820
[TBL] [Abstract][Full Text] [Related]
18. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
Vivekanandam V; Männikkö R; Skorupinska I; Germain L; Gray B; Wedderburn S; Kozyra D; Sud R; James N; Holmes S; Savvatis K; Fialho D; Merve A; Pattni J; Farrugia M; Behr ER; Marini-Bettolo C; Hanna MG; Matthews E
Brain; 2022 Jun; 145(6):2108-2120. PubMed ID: 34919635
[TBL] [Abstract][Full Text] [Related]
19. Andersen-Tawil syndrome: report of 3 novel mutations and high risk of symptomatic cardiac involvement.
Kostera-Pruszczyk A; Potulska-Chromik A; Pruszczyk P; Bieganowska K; Miszczak-Knecht M; Bienias P; Szczałuba K; Lee HY; Quinn E; Ploski R; Kaminska A; Ptáček LJ
Muscle Nerve; 2015 Feb; 51(2):192-6. PubMed ID: 24861851
[TBL] [Abstract][Full Text] [Related]
20. Hypokalemic periodic paralysis, facial dysmorphism and ventricular arrhythmia (clinical triad of Andersen-Tawil syndrome).
Thakkar M; Biswas TK; Desle HB
J Assoc Physicians India; 2012 Nov; 60():56-8. PubMed ID: 23767205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]